INTEGER HOLDINGS CORPORATION (ITGR) FY2026 Q2 P&L / Income Statement

INTEGER HOLDINGS CORPORATION (ITGR) FY2026 Q2 P&L / Income Statement

Income statement for 2026-04-04 through 2026-07-03. View: Product and service. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Sales

464,110,000 US dollars

Cost of sales

351,168,000 US dollars

Gross profit

112,942,000 US dollars

Total operating expenses

78,414,000 US dollars

Operating income

34,528,000 US dollars

Other income (expense), net (calculated)

negative 11,237,000 US dollars

Income from continuing operations before taxes

23,291,000 US dollars

Provision (benefit) for income taxes

negative 314,000 US dollars

Net income

23,605,000 US dollars

Cardio & Vascular

280,308,000 US dollars

Cardiac Rhythm Management & Neuromodulation

173,712,000 US dollars

Other Markets

10,090,000 US dollars

Selling, general and administrative

57,699,000 US dollars

Research, development and engineering

11,278,000 US dollars

Restructuring and other charges

9,437,000 US dollars

Loss from discontinued operations, net of tax

0 US dollars. Reported below-tax contribution to net income.

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit, plus the explicitly reported below-tax contributions, equals net income.